DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Employees

199

Sector

Medical Equipment, Supplies & Distribution

Calendar

23/07 - Annual General Meeting

More about the company

Quotes

Date	Price	Change	Volume
17/25/17	0.7000 $	-2.10%	2,83,134
16/25/16	0.7150 $	+0.85%	3,56,910
15/25/15	0.7090 $	+1.29%	65,980
14/25/14	0.7000 $	-2.64%	1,81,906
11/25/11	0.7190 $	+0.22%	1,50,758

Delayed Quote Nasdaq, July 18, 2025 at 01:30 am IST

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.7000USD

Average target price

2.375USD

Spread / Average Target

+239.29%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 01:30:00 18/07/2025 am IST			5-day change	1st Jan Change
0.7000 ^USD	-2.10%		-2.43%	-10.95%

11/07	DarioHealth Corp. Appoints Steven M. Nelson as President, Effective July 10, 2025	CI
26/06	Dariohealth Corp. and Greenkey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide	CI

Capitalization	3.11Cr 2.69Cr 2.5Cr 2.32Cr 4.28Cr 267.78Cr 4.8Cr 30Cr 11Cr 125.38Cr 12Cr 11Cr 462.23Cr	P/E ratio 2025 *	-0.84x	P/E ratio 2026 *	-1.02x
Enterprise value	3.11Cr 2.69Cr 2.5Cr 2.32Cr 4.28Cr 267.78Cr 4.8Cr 30Cr 11Cr 125.38Cr 12Cr 11Cr 462.23Cr	EV / Sales 2025 *	0.97x	EV / Sales 2026 *	0.83x
Free-Float	82.29%	Yield 2025 *	-	Yield 2026 *	-

DarioHealth Corp. Appoints Steven M. Nelson as President, Effective July 10, 2025	11/07	CI
Dariohealth Corp. and Greenkey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide	26/06	CI
DarioHealth Corp. Unveils GLP-1 and AI-Personalization Digital Health Findings	24/06	CI
DarioHealth Corp., Q1 2025 Earnings Call, May 14, 2025	22/05
Dariohealth Reports First Quarter 2025 Financial	14/05	RE
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	14/05	CI
DarioHealth Corp. Announces New Research Published in the Journal of Medical Internet Research	08/05	CI
Dariohealth Closes Strategic Refinancing of Existing Debt Facility of Up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives	01/05	CI
DarioHealth Corp. announced that it has received $32.5 million in funding from Rand Capital LLC, Callodine Group, LLC	01/05	CI
DarioHealth Announces CFO Transition	21/04	RE
DarioHealth Corp. Announces CFO Transition, Effective May 15, 2025	21/04	CI
Dariohealth Appoints Chen Franco-Yehudaas as New Treasurer and Secretary, Effective on May 15, 2025	21/04	CI
Dariohealth Collaborates With Leading National Benefit Plan Administrator To Offer Cardiometabolic Solution	17/04	RE

TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2	29/01	MT
Alliance Global Adjusts Price Target on DarioHealth to $4.10 From $5.45, Keeps Buy Rating	11/23/11	MT
Stifel Nicolaus Adjusts DarioHealth Price Target to $6 From $9, Maintains Buy Rating	25/23/25	MT
Craig-Hallum Adjusts DarioHealth's Price Target to $8 From $14, Keeps Buy Rating	12/23/12	MT
Alliance Global Partners Adjusts Price Target on DarioHealth to $7.50 From $9.15, Maintains Buy Rating	16/22/16	MT

DarioHealth Corp. Share Price

Equities

DRIO

US23725P2092

Medical Equipment, Supplies & Distribution

Valuation: DarioHealth Corp.

Chart: DarioHealth Corp.

Latest news: DarioHealth Corp.

Last Transcript: DarioHealth Corp.

Analysts' recommendations: DarioHealth Corp.

Press Releases: DarioHealth Corp.

News in other languages: DarioHealth Corp.

Quotes and Performance

Course Extremes

Managers and Directors: DarioHealth Corp.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly revenue - Rate of surprise

Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide	26/06	PR
DarioHealth Reports First Quarter 2025 Financial and Operating Results	14/05	PR
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations	08/05	PR
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025	07/05	PR
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives	01/05	PR

Los analistas financieros, ávidos de tratamientos contra la obesidad	20/23/20
Les analystes financiers avides de traitements anti-obésité	20/23/20

1 day	-2.10%
1 week	-2.43%
Current month	+4.48%
1 month	+1.30%
3 months	-6.67%
6 months	+0.86%
Current year	-10.95%

1 week	0.68	0.73
1 month	0.67	0.74
Current year	0.5	1.55
1 year	0.5	1.55
3 years	0.5	7.33
5 years	0.5	31.85
10 years	0.5	233.5

Manager	Title	Age	Since
Dov Oppenheim PRN	Corporate Officer/Principal	-	11/08/2011
Erez Raphael CEO	Chief Executive Officer	51	09/08/2013
Chen Franco-Yehuda DFI	Director of Finance/CFO	41	15/05/2025

Director	Title	Age	Since
Erez Raphael CHM	Chairman	51	23/11/2014
Dennis McGrath BRD	Director/Board Member	68	12/11/2013
Hila Karah BRD	Director/Board Member	56	23/11/2014

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DARIOHEALTH CORP.	-2.10%	-2.43%	-44.88%	-88.60%	3.11Cr
ABBOTT LABORATORIES	-8.52%	-9.80%	+15.12%	+10.74%	21TCr
MEDTRONIC PLC	-0.28%	+0.15%	+10.18%	+0.46%	11TCr
CENCORA, INC.	-1.16%	-0.99%	+30.74%	+106.99%	5.71TCr
BECTON, DICKINSON AND COMPANY	+1.48%	+1.92%	-22.71%	-24.39%	5.18TCr
HOYA CORPORATION	+0.46%	+3.31%	-4.33%	+46.85%	4.23TCr
DEXCOM, INC.	-0.04%	-1.59%	-26.62%	+6.27%	3.3TCr
TERUMO CORPORATION	-1.25%	-1.81%	-13.09%	+11.85%	2.43TCr
STERIS PLC	-1.33%	-2.66%	-1.80%	+7.33%	2.21TCr
SARTORIUS STEDIM BIOTECH	-0.75%	-6.22%	+11.28%	-43.73%	2.18TCr
Average	-0.41%	-1.84%	-4.61%	+3.38%	5.77TCr
Weighted average by Cap.	+0.04%	-3.64%	+6.48%	+15.31%

	2025 *	2026 *
Net sales	3.21Cr 2.77Cr 2.59Cr 2.4Cr 4.42Cr 276.53Cr 4.96Cr 31Cr 12Cr 129.48Cr 12Cr 12Cr 477.33Cr	3.77Cr 3.25Cr 3.03Cr 2.81Cr 5.18Cr 324.14Cr 5.81Cr 37Cr 14Cr 151.77Cr 14Cr 14Cr 559.5Cr
Net income	-3.95Cr -3.41Cr -3.18Cr -2.94Cr -5.43Cr -339.56Cr -6.09Cr -38Cr -14Cr -159Cr -15Cr -14Cr -586.13Cr	-3.71Cr -3.2Cr -2.98Cr -2.76Cr -5.1Cr -318.92Cr -5.72Cr -36Cr -14Cr -149.33Cr -14Cr -14Cr -550.49Cr
Net Debt	-	-